Vol. 49, No. 1, May 2021
The effects on sales volume share of value-added generic drugs
~A complex analysis of pharmaceutical companies’ motivation to develop value-added generic drugs~
 
Contents
 
EditorialKurihara M 4-5Full text
 
Originals
 The effects on sales volume share of value-added generic drugs
  ~A complex analysis of pharmaceutical companies’ motivation
   to develop value-added generic drugs~
Hamada C7-28Abstract
 A study on a strategic model to implement remote auditingTsutsumi N,Matsuyama K,
Nagashima H,Imamura K
29-39Full text
 
Proposals
 COVID-19 Control-Critical appraisals and proposals21st Century Advanced Medical Consortium 41-51Full text
 COVID-19 control-Critical appraisal and proposalsFukushima M 53-66Full text
 
Articles
 Ethics and regulation of military research involving human subjects
  (2) Analysis of French legislation and opinion paper on “enhanced soldier”
Nudeshima J 67-75Abstract
 Ophthalmic adverse reactions related to psychiatric medications:
  Focusing on benzodiazepine ophthalmopathy
Saio T 77-84Abstract
 Tentative overview on long COVID: SARS-CoV-2 leads to all kinds of diseaseSaio T 85-92Full text
 Science and ethics of clinical trial of COVID-19 preventive vaccines:
  Consideration on placebo and post-trial access
Kurihara C,Saio T,
Matsuyama K,Imamura K
93-108Full text
 
Forum
 A group of Patient Public Involvement (PPI) shared their feelings after reading
  “DECLARATION OF HELSINKI”:
   The atmosphere of the meeting is vividly reported with Graphic Recording
Yoshikawa K,Saeki H,
Tsutsumi N,Imamura K
109-15Full text
 
Instructions for authors[Japanese]&[English] 117-25Full text
 
Editor’s noteKageyama S 127Full text

Back to Rinsho Hyoka(Clinical Evaluation) home page
Back to Contents